Final Conference Details Posted for: CHIs Adopting Integrated R&D Informatics Systems
February 25-27, 2009 Moscone North Convention Center, San Francisco, CA http://www.tri-conference.com/09_ird.asp AGENDA-AT-A-GLANCE PRE-CONFERENCE SHORT COURSE* Tuesday, February 24 - 2:00 - 5:00 pm (SC6) Best Practices in Translational Medicine, Drug Discovery and Informatics This course provides you with an inside look at several of the outstanding Best Practices presented as a part of the 2008 Bio-IT World Best Practices competition. Speakers will present their best practices, give updates to the program and discuss pushing innovation, increasing ROI, and implementing strategies that are the best in the industry. The forum will be invaluable for building the innovative partnerships and strategies that will keep pushing the industry forward. * Separate registration is required. MAIN CONFERENCE February 25-27, 2009 INTEGRATED R&D - DRIVING PRODUCTIVITY, INNOVATION & MANAGING RESOURCES & COSTS PLENARY KEYNOTE: Using Molecular Medicine to do Therapeutic Development in the Network Age Jay M. Tenenbaum, Ph.D., Chairman and Chief Scientist, CollabRx, Inc. Scientific Workflows as Productivity Tools for Drug Discovery Juergen Hammer, Ph.D., M.Sc., M.B.A., Global Research Informatics Director, Group Research Information- Global Head in silico Sciences - Center Head - Liaison to Pharma Research, Hoffmann-La Roche Inc. The Role of Informatics and Genomics to Drive Innovation in Pharma Jakob DeVlieg, Ph.D., Global Head Molecular Design & Informatics, Molecular Design & Informatics, Schering-Plough Evolution of an Innovation Model to Support Pharma R&D Martin D. Leach, Ph.D., Executive Director, MRL IT Basic Research & Biomarkers, Merck & Co. Inc. RISé - Research Informatics System at RISé Ajay Shah, Ph.D., M.B.A., P.M.P., Director, Research Informatics, Elan Pharmaceuticals Inc. Sponsored by: Symyx Resource Management Strategies Impacting Systems Integration in R&D David M. Sedlock, Ph.D.. Senior Director, R&D Systems, Millennium Pharmaceuticals The TAKEDA Oncology Company Democratized Serendipity: Leveraging Consumer-Oriented Technologies into Better R&D and Better Health Care Decisions Joseph A. Cerro, President, The Schooner Group, LLC Executive Panel: Integrated R&D, How Far Have We Come? Moderator: Susan Ward, Ph.D.,Executive Advisor, Biotechnology & Pharma Panelists: All of the above speakers TRANSLATIONAL RESEARCH INFORMATICS Enterprise Information Integration to Inform Biomarker Discovery and Development: Clinical Patient, Biosample and Omics Data Gary Mallow, Ph.D., Director, Biomarker Programs, Information Services for Basic Research, Merck & Co., Inc. A Nationwide Network to Enable Translational Research Ken Buetow, Ph.D., NCI Associate Director, Bioinformatics and Information Technology and Director, Center for Biomedical Informatics and Information Technology, National Cancer Institute Translating Between Pre-clinical Data and Clinical Outcomes: Successes and Challenges Anastasia M. Khoury Christianson, Ph.D., Senior Director and Global Discipline Leader, Biomedical Informatics, AstraZeneca R&D Wilmington How to get the Most Out of Published Findings: Improving Information Flow and Knowledge Enrichment Throughout Discovery Nikolai Daraselia, Ph.D., Senior Director of Research, Ariadne Sponsored by Ariadne Scientific Informatics: The Integration of Information and Process to Achieve Knowledge Re-Use Frank K. Brown, Ph.D., Vice President & Chief Science Officer, Accelrys Sponsored by Accelrys Integrated Informatics - Are We There Yet? Sandor Szalma, Ph.D., Director, R&D Informatics, Centocor R&D Inc. Panel: Bridging the Divide Moderator: John Russell, Executive Editor, Bio-IT World Panelists: All of the above speakers Analysis of Genome-wide Genotyping Data for Copy Number Variation in Breast Cancer Aubree Hoover, Senior Product Manager, Rosetta Biosoftware Sponsored by Rosetta Biosoftware PLENARY KEYNOTE Engineering Cells to Death James A. Wells, Ph.D., Professor and Chair of Pharmaceutical Chemistry, and Professor of Cellular & Molecular Pharmacology, University of California, San Francisco PLENARY KEYNOTE Brave New Age of Personalized Medicine David Ewing Duncan, Chief Correspondent, NPR Talk's "Biotech Nation" and Best Selling Author "Masterminds" DATA, INFORMATION AND KNOWLEDGE MANAGEMENT Tales from the Edge: Advanced Approaches to Knowledge Integration & Search David M. Hodgson, Site Head, Global Research Informatics & Global Head, Group Knowledge Exchange, Roche A Strategy for Internal-External Data and Information Integration Jason M. Johnson, Ph.D., Senior Director, Molecular Informatics, Merck & Co., Inc. Accelerating Research Through Information Exploitation Chris Waller, Ph.D., Senior Director, Chemistry Informations, Research and Development Informatics, Worldwide Technology, Pfizer, Inc. Integrating Public and Private Data Reece Hart, Ph.D., Scientific Manager, Research Computing & Informatics, Genentech Inc. INTEGRATING GENOMIC DATA The Genomic Data Pipeline: Collecting, Cleaning, Analyzing, Integrating, Sharing Jeanette Papp, Ph.D., Associate Professor, Human Genetics, University of California, Los Angeles Surviving the Data Deluge: Informatics for Next Generation Sequencing Toby Bloom, Ph.D, Director of Informatics, Genome Sequencing Platform, The Broad Institute Integrating Public Genomics Data into Pharmaceutical R&D Hans-Martin Will, Ph.D., Senior Director, Genomics R&D, Rosetta Biosoftware Search Strategies for Correlating Combined Public and Internal Large-Scale Studies Ilya Kupershmidt, Cofounder and Vice President Products, NextBio Sponsored by NextBio Panel: Meeting of the Minds Those who Generate the Data with Those who Store, Analyze and Integrate Data DATA INTEGRATION AND MANAGEMENT FOR EARLY AND LATE CHEMISTRY Lilly's Transition from Paper to Electronic Lab Notebooks Keith DeVries, Ph.D., Director, Chemical Product, R&D, Eli Lilly and Company, Lilly Research Labs Integration of Chemical Genomics and Structural Biology Informatics: Novel Insights into the Kinase Gene Family? Stephan Schürer, Ph.D., Department of Pharmacology, Miller School of Medicine & Center for Computational Science, University of Miami Techniques for Effective Integrated Access to Large Compound-oriented Drug Discovery Databases Michael, Lajiness, Ph.D., Research Scientist, Structural and Computational Sciences, Eli Lilly & Company *separate registration is required to attend pre-conference short course. http://www.tri-conference.com/09_ird.asp For more information, contact: Cambridge Healthtech Institute Tel: 781-972-5400 E-mail: [EMAIL PROTECTED] _______________________________________________ BBB mailing list [email protected] http://www.bioinformatics.org/mailman/listinfo/bbb
